Chronic Kidney Disease
Obesity is not only comorbidity for chronic kidney disease (CKD) but may also be a risk factor for CKD. Epidemiological correlations and pathophysiological changes have been observed associating obesity with CKD. Low birth weight may be associated with both obesity and low nephron mass, leading to CKD later in life. Elevated levels of adipokines, such as leptin and adiponectin, in obesity may be factors in CKD pathogenesis and progression. Furthermore, various other factors, such as hypertension, increased cardiovascular morbidity, insulin resistance, dyslipidemia, and lipotoxicity, may play significant roles in the pathogenesis of CKD in obesity. Reduction in obesity, which is a potentially modifiable risk factor, might help decrease the burden of CKD in the population. Apart from individualized options, community-based interventions have the potential to create a strong impact in this condition.
- Increased Body Mass Index (BMI) and Risk of CKD
- Overweight and Progression of End-Stage Renal Disease (ESRD)
- Obesity, Metabolic Syndrome & the Risk of CKD
- Assess & Manage Obesity in the Setting of CKD
Related Conference of Chronic Kidney Disease
November 03-08 2015
Kidney Week 2015
San Diego USA
September 17-21 2016
15th Asian Pacific Congress of Nephrology APCN and ANZSN ASM
Perth Australia
March 03-06 2016
4th International Conference on PreHypertension Hypertension and CMS
Venice Italy
November 03-08 2015
American Society of Nephrology
San Diego USA
November 12-15 2015
Hands-On Abdominal Ultrasound Imaging Doppler
Dallas USA
February 27-March 1 2016
International Society for Peritoneal Dialysis
Melbourne Australia
Chronic Kidney Disease Conference Speakers
Recommended Sessions
- Vaccines for Obesity
- Antibiotics and Obesity
- Behavioral & Environmental Factors
- Biomedical Engineering and Obesity
- Cardiac Functional Changes
- Child Nutrition
- Childhood Obesity
- Childhood Obesity at Gene Level
- Childhood Obesity Prevention
- Chronic Kidney Disease
- Clinical Research
- Current Studies
- Diagnosis & Treatments
- Endocrine Disorders & Diabetes
- Exercise & Kinesiology
- Healthcare
- Impact of Steroids & Hormones
- Impact on Neurodegenerative Diseases
- Lifelong Effects
- Mushroom Supplement
- Obesity Surgery
- Paediatric Infectobesity
- Preventing Obesity from Infancy
- Pulmonary Function, Allergy & Immunity
- Rheumatic Diseases
- Treating Obesity by Therapeutic Approach
- Underserved Communities
- Visceral & Gastrointestinal Disorders
Related Journals
Are you interested in
- Advanced Treatment in Obesity - WORLD OBESITY-2024 (Spain)
- Anti-Obesity Drugs - Euro Obesity 2024 (UK)
- Anti-obesity drugs - WORLD OBESITY-2024 (Spain)
- Anti-Obesity Drugs and Weight-Loss Supplements - CHRONIC OBESITY 2024 (Indonesia)
- Ayurveda and Naturopathic Medicine - CHRONIC OBESITY 2024 (Indonesia)
- Bariatric Surgery - WORLD OBESITY-2024 (Spain)
- Behavioral Therapy - Euro Obesity 2024 (UK)
- Challenges and Prevention of Chronic Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Childhood Obesity - WORLD OBESITY-2024 (Spain)
- Childhood Obesity and Effects - Euro Obesity 2024 (UK)
- Chronic Respiratory Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Current Research on Obesity - CHRONIC OBESITY 2024 (Indonesia)
- Current research on obesity and diet - WORLD OBESITY-2024 (Spain)
- Diabesity: A Dual Challenge - WORLD OBESITY-2024 (Spain)
- Diabetes and Metabolic Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Diet & Nutrition - Euro Obesity 2024 (UK)
- Diet and nutrition - WORLD OBESITY-2024 (Spain)
- Dietary and Lifestyle changes - Euro Obesity 2024 (UK)
- Digital Therapeutics of Chronic Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Genetic Obesity - CHRONIC OBESITY 2024 (Indonesia)
- Genetics and Epigenetics of Obesity - WORLD OBESITY-2024 (Spain)
- Genetics of obesity - Euro Obesity 2024 (UK)
- Gynaecology & Obstetrics - Euro Obesity 2024 (UK)
- Gynecology and Obstetrics - WORLD OBESITY-2024 (Spain)
- HIV/ AIDS - CHRONIC OBESITY 2024 (Indonesia)
- Liposuction - Euro Obesity 2024 (UK)
- Liposuction and Advanced Weight Loss Treatments - CHRONIC OBESITY 2024 (Indonesia)
- Metabolic health - WORLD OBESITY-2024 (Spain)
- Morbid Obesity and Chronic Obstructive Pulmonary Disease (COPD) - CHRONIC OBESITY 2024 (Indonesia)
- Non-Surgical Treatment for Obesity - Euro Obesity 2024 (UK)
- Nutrition and Dietary Interventions - WORLD OBESITY-2024 (Spain)
- Nutritional counselling - WORLD OBESITY-2024 (Spain)
- Obesity - Euro Obesity 2024 (UK)
- Obesity - WORLD OBESITY-2024 (Spain)
- Obesity & Associated Health Disorders - Euro Obesity 2024 (UK)
- Obesity & Metabolic Disorders - Euro Obesity 2024 (UK)
- Obesity and Cancer - CHRONIC OBESITY 2024 (Indonesia)
- Obesity and Cardiovascular Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Obesity and Diabetes - Euro Obesity 2024 (UK)
- Obesity and Diet - CHRONIC OBESITY 2024 (Indonesia)
- Obesity and Endocrinology - Euro Obesity 2024 (UK)
- Obesity and Metabolic Diseases - WORLD OBESITY-2024 (Spain)
- Obesity and Pregnancy: Risk Factors - CHRONIC OBESITY 2024 (Indonesia)
- Obesity Causes - Euro Obesity 2024 (UK)
- Obesity Epidemiology - WORLD OBESITY-2024 (Spain)
- Obesity in Real Life - Euro Obesity 2024 (UK)
- Obesity in Teens and Adolescents - Euro Obesity 2024 (UK)
- Obesity in Teens and Adolescents - WORLD OBESITY-2024 (Spain)
- Obesity: Child, Teens, Adolescence - CHRONIC OBESITY 2024 (Indonesia)
- Obesity: Current research - Euro Obesity 2024 (UK)
- ozone therapy for obesity and chronic diseases - CHRONIC OBESITY 2024 (Indonesia)
- Paediatric Obesity - CHRONIC OBESITY 2024 (Indonesia)
- Physical activity, Exercise and Kinesiology - WORLD OBESITY-2024 (Spain)
- Prevention: Obesity - Euro Obesity 2024 (UK)
- Risk Factors Associated with Obesity - CHRONIC OBESITY 2024 (Indonesia)
- Roles of Steroids and Hormones in Obesity - WORLD OBESITY-2024 (Spain)
- Thyroid and Auto Immune Diseases - CHRONIC OBESITY 2024 (Indonesia)
- Weight Management - WORLD OBESITY-2024 (Spain)
- Yoga, Counselling and Physical Therapy - CHRONIC OBESITY 2024 (Indonesia)